NCT03003572View on ClinicalTrials.gov

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

RecruitingOBSERVATIONAL
Enrollment

185

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Primary Sjögren's Syndrome
Interventions
OTHER

Blood samples

Blood samples will be collected at inclusion to determine anti-Ro/SSA IgE titers (Enzyme Linked ImmunoSorbent Assay ELISA).

Trial Locations (8)

38300

NOT_YET_RECRUITING

CH Pierre Oudot, Bourgoin

38700

RECRUITING

CHU Grenoble Alpes, Grenoble

42055

RECRUITING

Chu Saint-Etienne, Saint-Etienne

63000

RECRUITING

CHU Estaing - Clermont Ferrand, Clermont-Ferrand

69317

RECRUITING

Hôpital de la Croix Rousse, Lyon

69495

RECRUITING

CH Lyon Sud, Lyon

Unknown

NOT_YET_RECRUITING

Hôpital Edouard Herriot - CHU Lyon, Lyon

NOT_YET_RECRUITING

CHU Reims, Reims

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER